Literature DB >> 16234847

Characterization of murine monoclonal antibodies against Helicobacter pylori lipopolysaccharide specific for Lex and Ley blood group determinants.

Eleonora Altman1, Blair A Harrison, Tomoko Hirama, Vandana Chandan, Rebecca To, Roger MacKenzie.   

Abstract

The cell envelope of Helicobacter pylori contains lipopolysaccharide (LPS), the O-chain of which expresses type 2 Lex and Ley blood group antigens, which mimic human gastric mucosal cell-surface glycoconjugates and may contribute to the survival of H. pylori in gastric mucosa. Here we describe the generation of monoclonal antibodies specific for Lex and Ley blood group determinants and the characterization of their binding properties using purified, structurally defined H. pylori LPS, synthetic glycoconjugates, and H. pylori cells. Analysis of oligosaccharide binding by SPR provided a rapid and reliable means for characterization of antibody affinities. One of the antibodies, anti-Lex, was of IgG3 subclass and had superior binding characteristics as compared with the commercially available anti-Lex IgM. These antibodies could have potential in the immunodiagnosis of certain types of cancer, in serotyping of H. pylori isolates, and in structure-function studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234847     DOI: 10.1139/o05-052

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  2 in total

1.  Lectin-like domain of thrombomodulin binds to its specific ligand Lewis Y antigen and neutralizes lipopolysaccharide-induced inflammatory response.

Authors:  Chung-Sheng Shi; Guey-Yueh Shi; Hsi-Min Hsiao; Shi-Ming Hsiao; Yuan-Chung Kao; Kuan-Lin Kuo; Chih-Yuan Ma; Cheng-Hsiang Kuo; Bi-Ing Chang; Chuan-Fa Chang; Chun-Hung Lin; Chi-Huey Wong; Hua-Lin Wu
Journal:  Blood       Date:  2008-08-18       Impact factor: 22.113

Review 2.  The role of thrombomodulin lectin-like domain in inflammation.

Authors:  Yi-Heng Li; Cheng-Hsiang Kuo; Guey-Yueh Shi; Hua-Lin Wu
Journal:  J Biomed Sci       Date:  2012-03-27       Impact factor: 8.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.